These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 10052895

  • 21. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C, van der Linden M, Reinert RR.
    Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
    [Abstract] [Full Text] [Related]

  • 22. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
    Bemer-Melchior P, Juvin ME, Tassin S, Bryskier A, Schito GC, Drugeon HB.
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
    [Abstract] [Full Text] [Related]

  • 23. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
    Farrell DJ, Jenkins SG.
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
    [Abstract] [Full Text] [Related]

  • 24. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
    Nagai K, Davies TA, Ednie LM, Bryskier A, Palavecino E, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3242-5. PubMed ID: 11600391
    [Abstract] [Full Text] [Related]

  • 25. [Antimicrobial activity of macrolides against clinical isolates].
    Hoshino K, Iwai Y, Nakamura S, Seto I, Yamaguchi K.
    Jpn J Antibiot; 1998 Apr; 51(4):249-71. PubMed ID: 9644599
    [Abstract] [Full Text] [Related]

  • 26. Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
    Calatayud L, Ardanuy C, Cercenado E, Fenoll A, Bouza E, Pallares R, Martín R, Liñares J.
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3240-6. PubMed ID: 17606677
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
    Yano H, Kobayashi T, Okitsu N, Aoki A, Toriya M, Nakada Y, Sagai H, Iyobe S, Inoue M.
    Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
    Morosini MI, Cantón R, Loza E, del Campo R, Almaraz F, Baquero F.
    J Antimicrob Chemother; 2003 Jul; 52(1):50-5. PubMed ID: 12805254
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance.
    Fernandes PB, Baker WR, Freiberg LA, Hardy DJ, McDonald EJ.
    Antimicrob Agents Chemother; 1989 Jan; 33(1):78-81. PubMed ID: 2523688
    [Abstract] [Full Text] [Related]

  • 37. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
    Jenkins SG, Brown SD, Farrell DJ.
    Ann Clin Microbiol Antimicrob; 2008 Jan 11; 7():1. PubMed ID: 18190701
    [Abstract] [Full Text] [Related]

  • 38. Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model.
    Esposito S, Noviello S, Ianniello F.
    J Chemother; 2000 Dec 11; 12(6):475-81. PubMed ID: 11154028
    [Abstract] [Full Text] [Related]

  • 39. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R, Sauermann R, Lagler H, Stich K, Buxbaum A, Graninger W, Georgopoulos A.
    Int J Antimicrob Agents; 2004 Sep 11; 24(3):290-3. PubMed ID: 15325435
    [Abstract] [Full Text] [Related]

  • 40. Erythromycin resistance in Streptococcus pyogenes in Italy.
    Bassetti M, Manno G, Collidà A, Ferrando A, Gatti G, Ugolotti E, Cruciani M, Bassetti D.
    Emerg Infect Dis; 2000 Sep 11; 6(2):180-3. PubMed ID: 10756153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.